Biology News
Global Molecular Biology Analyzers Market Forecast 2022 With Key Companies Profile, Demand, Supply, Cost Structure - The Financial


The Financial
Molecular Biology Analyzers Market Report is detail Analysis of past as well as future market trends of Molecular Biology Analyzers Market. The report showcases the business strategists, Growth Prospects and historical & futuristic cost and revenue ...

molecular biology - Hackaday


Hackaday
But if you're at all interested in the processes of modern molecular biology, make sure you watch the whole thing. The basic idea here is to create an innocuous virus that carries the lac gene, which encodes the enzyme β-galactosidase, or lactase, and ...

Biochemistry/Cell Biology Major and Molecular Biology Majors Combined Starting Fall 2018 - The Triton


The Triton
UC San Diego's Division of Biological Sciences is combining the Biochemistry/Cell Biology major and Molecular Biology major to form a new major, Molecular and Cell Biology, for students admitted after Fall 2018. The Biology Education Committee ...

Molecular Insight Pharmaceuticals

Cambridge, Massachusetts - United States

Molecular Insight is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery, development, and commercialization of targeted radiotherapeutics and molecular imaging pharmaceuticals for use in oncology that are intended to improve the lives of patients through timely and accurate detection, improved treatment, and effective monitoring of therapeutic response and disease progression. It has product candidates at various stages of development and/or in different phases in the regulatory approval process in the United States and Europe.

Related
AFT Pharmaceuticals - A New Force In Pharmaceuticals
New Zealand

AFT Pharmaceuticals is a privately owned company with operations in both Australia and New Zealand. The company was founded in 1997 by Dr Hartley Atkinson. AFT operates as a full service pharmaceutical company and also undertakes drug development activities including clinical trials. AFT has a growing portfolio of patented and niche pharmaceuticals which are in the process of being licensed for sale outside the Australasian market.

Insight Biotechnology Ltd.
United Kingdom

Supplier of thermostable DNA polymerases and restriction enzymes, antibodies and recombinant proteins from Wembley, England.

Eco Insight
United Kingdom

Eco Insight, in association with a network of specialists, provides a range of consulting services in the fields of ecology and conservation in Africa.

Insight Pharma Reports
United States

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts,

Disease Insight Research Foundation
United States

DIRF is a non-profit foundation dedicated to conquering common diseases such as cancer or mental illness through genetic research.

Prolexys Pharmaceuticals, Inc.
United States

Mapping protein-protein interactions and identify new targets for drug discovery to treat cancer and cardiovascular disease. Explains technology platforms and aetology targeted, with FAQ, company alliances and management in Salt Lake City, Utah.

MultiTarget Pharmaceuticals
United States

Manufacturer of AquaPlasmid, a system for the isolation of pure plasmid DNA. The procedure is simpler than alkaline lysis, but the DNA prep is purer than those purified by anion exchange columns, in Salt Lake City, Utah, USA.

Alnylam Pharmaceuticals
United States

Develops novel therapeutics based RNAi. Provides overview of recent drug development programs. Includes company profile and technology information.

Calando Pharmaceuticals
United States

Company developing non-viral technologies for the therapeutic use of RNAi.

RXi Pharmaceuticals
United States

Discovery-stage biotechnology company pursuing the development of RNAi therapeutics for the treatment of neurodegenerative disease, diabetes and obesity.